NEW YORK, Oct. 21 (GenomeWeb News) - Tata Consultancy Services of Mombai, India, and Israeli pharma BioStrx will co-develop lead drug compounds, the companies said last week.
The companies will collaborate on protein crystallization and structure determination to provide optimized lead compounds.
Tata Consultancy Services is a software developer and information technology consultancy. BioStrx provides protein crystallization and proteomics services.
Financial details of the deal were not disclosed.